Sarcopenia and physical frailty: Two sides of the same coin

Frontiers in Aging Neuroscience

Volumn 6, Issue JUL, 2014, Pages

  Cesari, Matteo ^a,b   Landi, Francesco ^c   Vellas, Bruno ^a,b   Bernabei, Roberto ^c   Marzetti, Emanuele ^c  

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ARTICLE; CLINICAL PRACTICE; FRAIL ELDERLY; HEALTH CARE SYSTEM; HUMAN; LEAN BODY WEIGHT; MUSCLE MASS; SARCOPENIA;

EID: 84904701574     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2014.00192     Document Type: Article

References (37)

1. Guralnik JM, Fried LP, Salive ME. Disability as a public health outcome in the aging population. Annu Rev Public Health. 1996;17:25-46.
2. Janssen I, Shepard DS, Katzmarzyk PT, Roubenoff R. The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc. 2004;52:80-85.
3. Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. 2013;381:752-762.
4. Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr. 1997;127:990S-991S.
5. Rodríguez-Mañas L, Féart C, Mann G et al. Searching for an Operational Definition of Frailty: A Delphi Method Based Consensus Statement. The Frailty Operative Definition- Consensus Conference Project. J Gerontol A Biol Sci Med Sci. 2012;68:62-67.
6. Theou O, Brothers TD, Pena FG, Mitnitski A, Rockwood K. Identifying common characteristics of frailty across seven scales. J Am Geriatr Soc. 2014;62:901-906.
7. Ferrucci L, Guralnik JM, Studenski S et al. Designing randomized, controlled trials aimed at preventing or delaying functional decline and disability in frail, older persons: a consensus report. J Am Geriatr Soc. 2004;52:625-634.
8. Abellan Van Kan G, Rolland YM, Andrieu S et al. Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force. J Nutr Health Aging. 2009;13:881-889.
9. Daniels R, van Rossum E, de Witte L, Kempen GI, van den Heuvel W. Interventions to prevent disability in frail community-dwelling elderly: a systematic review. BMC Health Serv Res. 2008;8:278.
10. Bauer JM, Sieber CC. Sarcopenia and frailty: a clinician's controversial point of view. Exp Gerontol. 2008;43:674-678.
11. Cesari M, Vellas B, Gambassi G. The stress of aging. Exp Gerontol. 2013;48:451-456.
12. Rolland Y, Abellan Van Kan G, Gillette-Guyonnet S, Vellas B. Cachexia versus sarcopenia. Curr Opin Clin Nutr Metab Care. 2011;14:15-21.
13. Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci. 2004;59:255-263.
14. Gordis L. The epidemiologic approach to disease and intervention. In: Gordis L, editor. Epidemiology. Philadelphia, PA: Saunders Elsevier; 2009. p. 1-17.
15. Subra J, Gillette-Guyonnet S, Cesari M, Oustric S, Vellas B. The integration of frailty into clinical practice: preliminary results from the gérontopôle. J Nutr Health Aging. 2012;16:714- 720.
16. Maggio M, Ceda GP, Lauretani F. The Multidomain Mobility Lab in Older Persons: From Bench to Bedside. Curr Pharm Des. 2014;20:3093-3094.
17. Fielding RA, Vellas B, Evans WJ et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc. 2011;12:249-256.
18. Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39:412-423.
19. Muscaritoli M, Anker SD, Argiles J et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics". Clin Nutr. 2010;29:154-159.
20. Morley JE, Abbatecola AM, Argiles JM et al. Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc. 2011;12:403-409.
21. Alley DE, Shardell MD, Peters KW et al. Grip strength cutpoints for the identification of clinically relevant weakness. J Gerontol A Biol Sci Med Sci. 2014;69:559-566.
22. Cawthon PM, Peters KW, Shardell MD et al. Cutpoints for low appendicular lean mass that identify older adults with clinically significant weakness. J Gerontol A Biol Sci Med Sci. 2014;69:567-575.
23. Dam TT, Peters KW, Fragala M et al. An evidence-based comparison of operational criteria for the presence of sarcopenia. J Gerontol A Biol Sci Med Sci. 2014;69:584-590.
24. McLean RR, Shardell MD, Alley DE et al. Criteria for Clinically Relevant Weakness and Low Lean Mass and Their Longitudinal Association With Incident Mobility Impairment and Mortality: The Foundation for the National Institutes of Health (FNIH) Sarcopenia Project. J Gerontol A Biol Sci Med Sci. 2014;69:576-583.
25. Studenski SA, Peters KW, Alley DE et al. The FNIH Sarcopenia Project: Rationale, Study Description, Conference Recommendations, and Final Estimates. J Gerontol A Biol Sci Med Sci. 2014;69:547-558.
26. Morley JE, Vellas B, Abellan Van Kan G et al. Frailty consensus: a call to action. J Am Med Dir Assoc. 2013;14:392-397.
27. Straus SE, McAlister FA. Evidence-based medicine: a commentary on common criticisms. CMAJ. 2000;163:837-841.
28. Scott IA, Guyatt GH. Cautionary tales in the interpretation of clinical studies involving older persons. Arch Intern Med. 2010;170:587-595.
29. Dickinson MH, Farley CT, Full RJ, Koehl MA, Kram R, Lehman S. How animals move: an integrative view. Science. 2000;288:100-106.
30. Carter CS, Marzetti E, Leeuwenburgh C et al. Usefulness of Preclinical Models for Assessing the Efficacy of Late-Life Interventions for Sarcopenia. J Gerontol A Biol Sci Med Sci. 2012;67:17-27.
31. Cummings SR, Studenski S, Ferrucci L. A Diagnosis of Dismobility-Giving Mobility Clinical Visibility: A Mobility Working Group Recommendation. JAMA. 2014;311:2061-2062.
32. Studenski S, Perera S, Wallace D et al. Physical performance measures in the clinical setting. J Am Geriatr Soc. 2003;51:314-322.
33. Guralnik JM, Ferrucci L, Simonsick EM, Salive ME, Wallace RB. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med. 1995;332:556-561.
34. Studenski S, Perera S, Patel K et al. Gait speed and survival in older adults. JAMA. 2011;305:50-58.
35. Guralnik JM, Simonsick EM, Ferrucci L et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994;49:M85-M94.
36. Lauretani F, Russo CR, Bandinelli S et al. Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol. 2003;95:1851- 1860.
37. Rantanen T, Guralnik JM, Foley D et al. Midlife hand grip strength as a predictor of old age disability. JAMA. 1999;281:558-560.